Benchmark Upgrades Neogenomics (NEO) to Buy, 'Reorganization Plan Looks Doable'
Tweet Send to a Friend
(Updated - February 24, 2023 6:04 AM EST)
Benchmark analyst Bruce Jackson upgraded Neogenomics (NASDAQ: NEO) from Hold to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Benchmark analyst Bruce Jackson upgraded Neogenomics (NASDAQ: NEO) from Hold to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
